IMPROVEMENT IN IWQOL-LITE-DERIVED HEALTH UTILITY SCORE WITH LIRAGLUTIDE 3.0 MG VERSUS PLACEBO OVER 3 YEARS IN PREDIABETES
May 1, 2016, 00:00 AM
10.1016/j.jval.2016.03.1000
https://www.valueinhealthjournal.com/article/S1098-3015(16)01068-8/fulltext
Section Title :
Systemic Disorders/Conditions - Patient-Reported Outcomes & Patient Preference Studies
Section Order :
935
First Page :
A251
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01068-8&doi=10.1016/j.jval.2016.03.1000